AACR Annual Meeting 2023 AACR 2023: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Patients With Resectable NSCLC
Graft-vs.-Host Disease Ruxolitinib for graft-versus-host disease prophylaxis following tacrolimus toxicity: A case series
Melanoma General Practitioner Sex and Documented Cancer Prevalence in German Primary Care: A Matched Cross-Sectional Study
Genitourinary Cancers Radiopharmaceuticals for Treatment of Metastatic Castration-Resistant Prostate Cancer
